Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.
Mindaugas PaužuolisTorsten EichJoachim BurmanPublished in: PloS one (2017)
Quantification of γδ T cells and HLA-DR+ NK cells could not predict active disease after NTZ suspension.